Your trusted source for investing success

Tag: TSE

Fintech Investing Facts

Fintech Investing Facts

You might not know it, but in simple terms fintech has been around for over a century. Here are some basic facts every investor should know about.

Avrupa Minerals Options Alvito IOCG Project to OZ Minerals

Avrupa Minerals Options Alvito IOCG Project to OZ Minerals

Avrupa Minerals (TSXV:AVU) is pleased to announce that it has signed an earn-in option agreement with Australia-based OZ Exploration Pty. Ltd. (OZE), a wholly-owned subsidiary of OZ Minerals Limited (OZM), to explore on the Alvito iron oxide, copper-gold (IOCG) project located in southern Portugal. The agreement allows for OZE

Maxtech Ventures Acquires Manganese Claims in Brazil

Maxtech Ventures Acquires Manganese Claims in Brazil

Maxtech Ventures Inc. has closed an arm’s-length binding agreement to acquire 9,999.23 hectares of additional mineral claims with indications of manganese in the state of Amazonas, Brazil. The terms of the acquisition include the payment of $35,000 (U.S.) and the issuance of 300,000 common shares of Maxtech, the transaction is

Plateau Uranium Drills 3 m of 2,160 ppm Uranium

Plateau Uranium Drills 3 m of 2,160 ppm Uranium

Plateau Uranium Inc. (TSXV:PLU) has released strong initial drill results from the high-grade Pinocho target at the company’s Macusani Plateau project in southeastern Peru. Initial results from six (6) diamond drill holes drilled on two (2) platforms are reported from Pinocho, which represents one of the most prospective of several

Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn’s Disease Patients with Cx601

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG)  (“TiGenix”) today announced new data from the Phase 3 ADMIRE-CD clinical trial, which indicated  that investigational compound Cx601, a suspension of allogeneic adipose-derived stem cells (eASC), maintained long-term remission of treatment refractory complex perianal fistulas

Nano Dimension’s Amit Dror

Nano Dimension’s Amit Dror

Nano Dimension CEO Amit Dror shares his outlook on the 3D printing market, discusses Nano’s collaboration with the Israeli Ministry of Defense, and the innovative solutions the company is bringing to the electronics industry.

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network